Phathom PharmaceuticalsPHAT

那斯達克 · USD
14.57
+0.02
(+0.14%)
收盤 12/12 04:58 (UTC+8)
盤後 
15.00 
+0.43 
(+2.95%)
12/12 04:58 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • 0.01
  • 0.02
  • 0.07
  • 0.16
  • 0.30
  • 0.29
  • 0.40
  • 0.50
icon
  • -
  • -
  • -
  • 180.35
  • 283.05
  • 123.27
  • 81.41
  • -3.86
  • 38.52
  • 25.31
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
49,503
39,504
28,519
29,664
16,352
7,324
1,912
682
-
-
營業成本
6,1895,0383,7243,8152,3561,376426167--
營業毛利
43,314
34,466
24,795
25,849
13,996
5,948
1,486
515
-
-
營業費用
58,58694,389103,658---71,44070,39035,65931,701
研發費用
7,0279,0769,1848,5838,6937,3769,43013,39412,26312,763
推銷及管理費用
51,55985,31394,47476,68376,09975,87262,01056,99623,39618,938
非經常性項目費用
----------
其他營業費用
----------
營業利益
-15,272
-59,923
-78,863
-59,417
-70,796
-77,300
-69,954
-69,875
-35,659
-31,701
其他收入及費用
1,4071,6302,6183,5593,7033,6184,2703,3342,523351
利息費用
16,10817,51718,07118,59318,48417,76417,16813,02910,1079,615
稅前純益
-29,973
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
-79,570
-43,243
-40,965
所得稅
----------
稅後純益
-29,973
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
-79,570
-43,243
-40,965
基本每股稅後盈餘(元)
-0.41-1.05-1.31-1.05-1.32-1.56-1.42--0.76-0.84
稀釋每股稅後盈餘(元)
-0.41-1.05-1.31-1.00-1.31-1.56-1.42-1.45-0.75-0.84
基本平均股數(千股)
73396.0072466.0071969.0071044.0064627.0058558.0058371.00-56782.0048500.00
稀釋平均股數(千股)
73396.0072466.0071969.0071044.0064627.0058558.0058371.00-56782.0048500.00
還原基本每股稅後盈餘(元)
-0.41-1.05-1.31-1.05-1.32-1.56-1.42--0.76-0.84
還原稀釋每股稅後盈餘(元)
-0.41-1.05-1.31-1.00-1.31-1.56-1.42-1.45-0.75-0.84
還原基本平均股數(千股)
73,39672,46671,96971,04464,62758,55858,371-56,78248,500
還原稀釋平均股數(千股)
73,39672,46671,96971,04464,62758,55858,371-56,78248,500
EBITDA(千元)
-12,934-57,387-75,372-55,036-66,313-72,985-64,996-65,790-32,473-30,954

大家都在看

HOT